ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 83 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $28,000 | -83.3% | 2,877 | -79.1% | 0.00% | – |
| Q4 2020 | $168,000 | +290.7% | 13,796 | +231.5% | 0.00% | – |
| Q3 2020 | $43,000 | -65.9% | 4,162 | -30.3% | 0.00% | – |
| Q2 2020 | $126,000 | +59.5% | 5,971 | -12.4% | 0.00% | – |
| Q4 2019 | $79,000 | +203.8% | 6,817 | +44.0% | 0.00% | – |
| Q3 2019 | $26,000 | -51.9% | 4,735 | +5.2% | 0.00% | – |
| Q2 2019 | $54,000 | +2600.0% | 4,502 | +486.2% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 768 | +104.3% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 376 | -2.8% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 387 | -64.5% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 1,089 | +34.6% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 809 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | – | 809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $85,866,000 | 42.72% |
| Versant Venture Management, LLC | 7,003,892 | $146,241,265,000 | 21.01% |
| ACUTA CAPITAL PARTNERS, LLC | 1,746,500 | $36,467,000 | 10.54% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $10,022,000 | 5.33% |
| Ghost Tree Capital, LLC | 900,000 | $18,792,000 | 4.96% |
| RTW INVESTMENTS, LP | 6,790,027 | $141,776,000 | 3.99% |
| RA Capital Management | 7,801,641 | $162,898,000 | 3.17% |
| Avoro Capital Advisors LLC | 7,585,000 | $158,375,000 | 3.13% |
| FRAZIER MANAGEMENT LLC | 1,437,028 | $30,005,000 | 2.64% |
| Soleus Capital Management, L.P. | 218,723 | $4,566,000 | 2.60% |